Multicenter Study English Abstract Journal Article Ppublish 4 citations
PubMed: 35914734 DOI: 10.1016/j.gofs.2022.07.004
[SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].
Gynecol Obstet Fertil Senol 50(11):712-720
Authors: M Huré, V Peyronnet, J Sibiude, M G Cazenave, O Anselem, D Luton, C Vauloup-Fellous, P Deruelle, A G Cordier, A Benachi, L Mandelbrot, C Couffignal, V Pauphilet, A J Vivanti, O Picone
Affiliations
- Assistance publique-Hôpitaux de Paris, AP-HP Nord, hôpital Louis-Mourier, service de gynécologie obstétrique, Colombes, France; Université Paris Cité, France.
- Assistance publique-Hôpitaux de Paris, AP-HP Nord, hôpital Louis-Mourier, service de gynécologie obstétrique, Colombes, France.
- Assistance publique-Hôpitaux de Paris, AP-HP Nord, hôpital Louis-Mourier, service de gynécologie obstétrique, Colombes, France; Université Paris Cité, France; Inserm, IAME, 75018 Paris, France; FHU PREMA, Paris, France.
- Assistance publique-Hôpitaux de Paris, AP-HP Nord, hôpital Bichat, département de recherche clinique, biostatistiques et épidémiologie, 75018 Paris, France; Maternité Port-Royal, hôpital Cochin, AP-HP, centre-université de Paris, Paris, France.
- Université Paris Cité, France; FHU PREMA, Paris, France; Service de gynécologie-obstétrique, université Paris Cité, FHU prématurité, hôpital Bichat, Assistance publique-Hôpitaux de Paris, 46, rue Henri-Huchard, Paris, France.
- Groupe de recherche sur les infections pendant la grossesse (GRIG), Vélizy, France; Hôpital universitaire, AP-HP, département de virologie, département de biologie génétique et PUI, université Paris Saclay, Villejuif, France; Inserm U1193, université Paris Saclay, Villejuif, France.
- Pôle de gynécologie obstétrique, hôpitaux universitaires de Strasbourg, Strasbourg, France.
- Université Paris Cité, France; Département de gynécologie et obstétrique, DMU santé des femmes et des nouveau-nés, hôpital Antoine-Béclère, université Paris Saclay, AP-HP, France.
- Département de gynécologie et obstétrique, DMU santé des femmes et des nouveau-nés, hôpital Antoine-Béclère, université Paris Saclay, AP-HP, France.
- Université Paris Cité, France; Inserm, IAME, 75018 Paris, France; Assistance publique-Hôpitaux de Paris, AP-HP Nord, hôpital Bichat, département de recherche clinique, biostatistiques et épidémiologie, 75018 Paris, France.
- Université Paris Cité, France; Maternité hôpital Robert-Debré, AP-HP, France.
- Département de gynécologie et obstétrique, DMU santé des femmes et des nouveau-nés, hôpital Antoine-Béclère, université Paris Saclay, AP-HP, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), Vélizy, France.
- Assistance publique-Hôpitaux de Paris, AP-HP Nord, hôpital Louis-Mourier, service de gynécologie obstétrique, Colombes, France; Université Paris Cité, France; Inserm, IAME, 75018 Paris, France; FHU PREMA, Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), Vélizy, France.
Abstract
OBJECTIVE
SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-19 vaccination and factors associated in women during their pregnancy.
MATERIAL AND METHOD
Multicenter cross-sectional survey study conducted from September to December 2021 with online self-questionnaire. All postpartum patients hospitalized in one of the 6 participating maternity hospitals were invited to answer. The questionnaire asked patients about their demographic characteristics, vaccination modalities, vaccine tolerance, and their general perception of vaccination.
RESULTS
Of the 371 women who responded, the vaccination rate was 65.7% (IC95% [60.8-70.4]), whom 98.8% entirely during pregnancy. Associated factors with vaccination during pregnancy were older age, higher socio-professional category, and prior information provided by health professionals. Factors that appear to motivate vaccination were personal protection and protection of the newborn. Finally, main factors negatively influencing the vaccination process were the fear of vaccine side effects and the negative perception of vaccines in general.
DISCUSSION
Acceptability and information about the vaccine by health professionals is in constant improvement. Information campaigns should be continued to improve the acceptability of vaccination, in light of the accumulating data.
MeSH
Genital Diseases, Female, Pregnant Women, Pregnancy, Sars-Cov-2, Cross-Sectional Studies, Vaccines, Perception, Vaccination, Severe Acute Respiratory Syndrome-Related Coronavirus, Postpartum Period
Cited by
- [P. Sookaromdee et V. Wiwanitkit. in reply to the article by O. Picone et al. entitled "SARS-Cov-2Â vaccine's acceptance among pregnant women: A cross-sectional survey" Gynecol Obstet Fertil 2022;50(11): Doi: 10.1016/j.gofs.2022.07.004]. Gynecol Obstet Fertil Senol, 2023
- Acceptability of the social uses of the COVID-19 screening test among women in southern Benin. J Public Health Afr, 2025
- COVID-19 Vaccination Rates and Factors Affecting Vaccine Hesitancy among Pregnant Women during the Pandemic Period in Turkey: A Single-Center Experience. Vaccines (Basel), 2022